Cell-free combination, hydrogel-like material or hydrogel and use of same

US11324855B2 · kind B2 · utility

Assignee

• TETEC Tissue Engineering Technologies AG · DE

Inventors

• Christoph Gaissmaier · Tübingen, DE
• Nils Clausen · Lörrach, DE
• Karin Benz · Eppingen, DE

Key dates

• Filing date: Apr 24, 2018
• Grant date: May 10, 2022
• Expiry date: Apr 24, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61L2430/40
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A cell-free combination for use in the controlled, especially decelerated or retarded, release of active ingredient and/or in the production of a formulation in hydrogel form, especially depot formulation in hydrogel form, and/or as a formulation in hydrogel form, especially depot formulation in hydrogel form, and/or for the coating of a medical product, especially implant, preferably with a formulation in hydrogel form, especially depot formulation in hydrogel form, wherein the cell-free combination comprises a first component and a second component, the first component comprising crosslinkable albumin and the second component comprising a crosslinking agent for the albumin. Additionally, a hydrogel-forming material or hydrogel, to a kit or multicomponent system, to a medical product or a pharmaceutical formulation, to a discharge device, and to uses of the cell-free combination and of the hydrogel-forming material or hydrogel.